Vigil Neuroscience Inc (VIGL)

Panoramica Notizia Cronologia dei prezzi Financials Perché VIGL Giù? Forum Previsione

Perché le azioni Vigil Neuroscience Inc (VIGL) sono in ribasso?

Abbiamo notato un calo di 7.84% nelle azioni di Vigil Neuroscience Inc (VIGL) durante la sessione di negoziazione di 2024-11-18. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!

2023-11-17:

Vigil Neuroscience Stock (VIGL) dropped by 40.03% from $6.67 to $4.00 in the trading on Friday November 17, 2023. The reason why VIGL stock down today is due to the interim data from its Phase 2 IGNITE proof-of-concept clinical trial in patients with ALSP. The data, representing the first six patients following six months of treatment with 20 mg/kg of iluzanebart, supports the drug's safety and tolerability, and showed target engagement and downstream pharmacological activity, consistent with Phase 1 data. Directionally supportive changes were observed on MRI and NfL biomarkers of disease progression in individual patients, and the company expects to report full Phase 2 IGNITE results in Q3 2024.

INCY

$70.39

0.93%

SMMT

$18.42

1.07%

MRNA

$38.25

3.55%

UTHR

$367.36

0.83%

BGNE

$194.56

0.15%

BNTX

$108.23

5.96%

Vigil Neuroscience Inc (VIGL)

Perché le azioni Vigil Neuroscience Inc (VIGL) sono in ribasso?

Simile a VIGL